Skin treatment developer Dermira seeks up to $75M in IPO

Dermira, a biotech company working on treatments for psoriasis and other skin problems, plans to seek up to $75 million in an IPO...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.